IV immunoglobulin confounds JC virus antibody serostatus determination

por Kister, Ilya, Kuesters, Geoffrey, Chamot, Eric, Omari, Mirza, Dontas, Kim, Yarussi, Mary, Subramanyam, Meena, Herbert, Joseph
Publicado 2014

Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy

por Plavina, Tatiana, Subramanyam, Meena, Bloomgren, Gary, Richman, Sandra, Pace, Amy, Lee, Sophia, Schlain, Brian, Campagnolo, Denise, Belachew, Shibeshih, Ticho, Barry
Publicado 2014

Changes to anti-JCV antibody levels in a Swedish national MS cohort

por Warnke, Clemens, Ramanujam, Ryan, Plavina, Tatiana, Bergström, Tomas, Goelz, Susan, Subramanyam, Meena, Kockum, Ingrid, Rahbar, Afsar, Kieseier, Bernd C, Holmén, Carolina, Olsson, Tomas, Hillert, Jan, Fogdell-Hahn, Anna
Publicado 2013

Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients

por Plavina, Tatiana, Muralidharan, Kumar Kandadi, Kuesters, Geoffrey, Mikol, Daniel, Evans, Karleyton, Subramanyam, Meena, Nestorov, Ivan, Chen, Yi, Dong, Qunming, Ho, Pei-Ran, Amarante, Diogo, Adams, Alison, De Sèze, Jerome, Fox, Robert, Gold, Ralf, Jeffery, Douglas, Kappos, Ludwig, Montalban, Xavier, Weinstock-Guttman, Bianca, Hartung, Hans-Peter, Cree, Bruce A.C.
Publicado 2017

Challenges and approaches for the development of safer immunomodulatory biologics

por Sathish, Jean G., Sethu, Swaminathan, Bielsky, Marie-Christine, de Haan, Lolke, French, Neil S., Govindappa, Karthik, Green, James, Griffiths, Christopher E. M., Holgate, Stephen, Jones, David, Kimber, Ian, Moggs, Jonathan, Naisbitt, Dean J., Pirmohamed, Munir, Reichmann, Gabriele, Sims, Jennifer, Subramanyam, Meena, Todd, Marque D., Van Der Laan, Jan Willem, Weaver, Richard J., Park, B. Kevin
Publicado 2013